Boosters, Cures 2.0, and the next pandemic

Boosters for all adults are here. Everyone over 18 “may” receive a booster shot six months after receiving their second Pfizer-BioNTech or Moderna shot, and “should” receive a booster two months after receiving one dose of Johnson & Johnson’s vaccine, per CDC guidance released Friday.

Do you have questions about boosters or mixing vaccines? has answers.

The innovative environment that allowed biotech firms to develop COVID-19 vaccines in record time would get a shot in the arm from Cures 2.0, an update to the 21st Century Cures Act—read the bill and a summary.

The bipartisan legislation introduced Tuesday would help modernize and increase diversity in clinical trials, increase patient education on and access to treatment options, incentivize research on drugs to fight antimicrobial resistance, and establish an agency to research the most difficult diseases.

“Cures 2.0 could help ensure scientists, researchers and entrepreneurs have the policy and regulatory environment they need to develop new medicines for patients around the globe,” said BIO President and CEO Dr. Michelle McMurry-Heath.

Federal funding helped produce research on how to address the threat of a potentially devastating flu pandemic. The National Academy of Medicine released four reports covering global coordination, supply chains, non-vaccine interventions, and R&D.

We need to develop a “universal influenza vaccine” ahead of the next pandemic, says Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative, co-authored by Phyllis Arthur, BIO’s VP of Infectious Diseases and Emerging Science Policy—read the key findings or watch the report release.

“A major influenza pandemic is more a matter of ‘when’ than ‘if,’” says the report, which has detailed recommendations like better coordination of governance and greater investment into research.


About The Author

Scroll to Top